Neurology
3 drugs are in development for Migraine.
- Companies
- 3
- Clinical trials
- 46
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Migraine pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Ubrogepant | AbbVie Inc. (ABBV) |
Preclinical(1)
| Drug | Company |
|---|---|
| ald1910 | ALDER BIOPHARMACEUTICALS INC (ALDR) |
BLA Filed(1)
| Drug | Company |
|---|---|
| m207 | Zosano Pharma Corp (ZSAN) |
About this indication
Migraine context
Neurology·MeSH: Migraine Disorders (D008881)
Also known as: Disorder, Migraine, Disorders, Migraine, Headache, Migraine, Headaches, Migraine, Migraines
Prevalence
15000.0 / 100K
Incidence
1500.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Migraine?
BioSniper tracks 3 drugs in development for Migraine across 3 companies.
How many clinical trials target Migraine?
There are 46 clinical trials targeting Migraine tracked by BioSniper.
What is the prevalence of Migraine?
The estimated prevalence of Migraine is approximately 15000.0 per 100,000 population.